| 摘要 |
The invention comprises the compound of formula <FORM:0977237/C1/1> and non-toxic acid addition salts thereof, and its preparation by subjecting a lower alkyl (1-4C) ester of 4-(21-carboxyphenylamino)-7-chloroquinoline to transesterification with b -morpholino ethanol. Pharmaceutical compositions comprise the compound and salts of the invention with pharmaceutical carriers or excipients. Tablets, pills, capsules and ampoules for injection are mentioned for the treatment of inflammatory and painful conditions. Specification 964,143 is referred to. |
